Cargando…

Clinical outcomes of MR-guided adrenal stereotactic ablative radiotherapy with preferential sparing of organs at risk

BACKGROUND AND PURPOSE: The optimal stereotactic ablative radiotherapy (SABR) doses for adrenal tumors are unknown. Some trials have specified that organ at risk (OAR) dose constraints should take priority over target coverage. We performed a retrospective review of the outcomes of MR-guided adrenal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schneiders, Famke L., van Vliet, Claire, Giraud, Nicolas, Bruynzeel, Anna M.E., Slotman, Ben J., Palacios, Miguel A., Senan, Suresh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10551830/ https://www.ncbi.nlm.nih.gov/pubmed/37808454 http://dx.doi.org/10.1016/j.ctro.2023.100680

Ejemplares similares

Renal atrophy following gated delivery of stereotactic ablative radiotherapy to adrenal metastases
por: van Sörnsen de Koste, John R., et al.
Publicado: (2021)

Same-day consultation, simulation and lung Stereotactic Ablative Radiotherapy delivery on a Magnetic Resonance-linac
por: Palacios, Miguel A., et al.
Publicado: (2022)

The Role of Daily Adaptive Stereotactic MR-Guided Radiotherapy for Renal Cell Cancer
por: Tetar, Shyama U., et al.
Publicado: (2020)

Adrenal oligometastasis cured with stereotactic ablative radiotherapy
por: Malone, Julia, et al.
Publicado: (2020)

Developments in radiation techniques for thoracic malignancies
por: Finazzi, Tobias, et al.
Publicado: (2021)

Delivery of magnetic resonance-guided single-fraction stereotactic lung radiotherapy
por: Finazzi, Tobias, et al.
Publicado: (2020)

Stereotactic ablative radiotherapy for the comprehensive treatment of 4–10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial
por: Palma, David A., et al.
Publicado: (2019)

The Role of Stereotactic Ablative Radiotherapy for Early-Stage and Oligometastatic Non-small Cell Lung Cancer: Evidence for Changing Paradigms
por: Dahele, Max, et al.
Publicado: (2011)

Stereotactic magnetic resonance-guided online adaptive radiotherapy of adrenal metastases combines high ablative doses with optimized sparing of organs at risk
por: Hoegen, Philipp, et al.
Publicado: (2022)

Technical know‐how in stereotactic ablative radiotherapy (SABR)
por: Lo, Simon S., et al.
Publicado: (2016)

Optimizing patient selection for stereotactic ablative radiotherapy in patients with locally advanced pancreatic cancer after initial chemotherapy - a single center prospective cohort
por: Doppenberg, D., et al.
Publicado: (2023)

Stereotactic MR-Guided Radiotherapy for Adrenal Gland Metastases: First Clinical Results
por: Michalet, Morgan, et al.
Publicado: (2022)

Stereotactic ablative radiotherapy for comprehensive treatment of oligometastatic tumors (SABR-COMET): Study protocol for a randomized phase II trial
por: Palma, David A, et al.
Publicado: (2012)

Salvage surgery for local failures after stereotactic ablative radiotherapy for early stage non-small cell lung cancer
por: Verstegen, Naomi E., et al.
Publicado: (2016)

Stereotactic radiotherapy for adrenal oligometastases
por: Borghesi, Simona, et al.
Publicado: (2022)

Clinical implementation of magnetic resonance imaging guided adaptive radiotherapy for localized prostate cancer
por: Tetar, Shyama U., et al.
Publicado: (2019)

Once‐a‐week or every‐other‐day urethra‐sparing prostate cancer stereotactic body radiotherapy, a randomized phase II trial: 18 months follow‐up results
por: Zilli, Thomas, et al.
Publicado: (2020)

Health-related quality of life of salvage prostate reirradiation using stereotactic ablative radiotherapy with urethral-sparing
por: Greco, Carlo, et al.
Publicado: (2022)

Sparing the contralateral submandibular gland without compromising PTV coverage by using volumetric modulated arc therapy
por: Doornaert, Patricia, et al.
Publicado: (2011)

Online MR-guided radiotherapy – A new era in radiotherapy
por: Slotman, B., et al.
Publicado: (2019)

Advances in Radiobiology of Stereotactic Ablative Radiotherapy
por: Qiu, Bin, et al.
Publicado: (2020)

The clinical introduction of MR-guided radiation therapy from a RTT perspective
por: Botman, R., et al.
Publicado: (2019)

Adaptive MR-Guided Stereotactic Radiotherapy is Beneficial for Ablative Treatment of Lung Tumors in High-Risk Locations
por: Regnery, Sebastian, et al.
Publicado: (2022)

Magnetic resonance imaging-guided radiotherapy for intermediate- and high-risk prostate cancer: Trade-off between planning target volume margin and online plan adaption
por: Tetar, Shyama U., et al.
Publicado: (2022)

The Confluence of Stereotactic Ablative Radiotherapy and Tumor Immunology
por: Finkelstein, Steven Eric, et al.
Publicado: (2011)

Stereotactic Ablative Radiotherapy for Oligometastatic Disease in Liver
por: Kim, Myungsoo, et al.
Publicado: (2014)

Stereotactic ablative radiotherapy for oligometastatic prostate cancer
por: Gallizia, Elena, et al.
Publicado: (2022)

Critical Structure Sparing in Stereotactic Ablative Radiotherapy for Central Lung Lesions: Helical Tomotherapy vs. Volumetric Modulated Arc Therapy
por: Chi, Alexander, et al.
Publicado: (2013)

MR‐Linac guided adaptive stereotactic ablative body radiotherapy for recurrent cardiac sarcoma with mitral valve bioprosthesis – a case report
por: Batumalai, Vikneswary, et al.
Publicado: (2023)

Minimally Invasive Stereotactical Radio-ablation of Adrenal Metastases as an Alternative to Surgery
por: Franzese, Ciro, et al.
Publicado: (2017)

Stereotactic ablative radiotherapy for the comprehensive treatment of 1–3 Oligometastatic tumors (SABR-COMET-3): study protocol for a randomized phase III trial
por: Olson, Robert, et al.
Publicado: (2020)

Organizing pneumonia after stereotactic ablative radiotherapy of the lung
por: Murai, Taro, et al.
Publicado: (2012)

Commissioning and initial stereotactic ablative radiotherapy experience with Vero
por: Solberg, Timothy D., et al.
Publicado: (2014)

Stereotactic ablative body radiotherapy in patients with prostate cancer
por: Loblaw, Andrew, et al.
Publicado: (2018)

Feasibility of split-course stereotactic ablative radiotherapy for oligometastases
por: Paik, Eun Kyung, et al.
Publicado: (2018)

Stereotactic ablative radiotherapy in patients with refractory ventricular tachyarrhythmia
por: Molon, Giulio, et al.
Publicado: (2022)

Feasibility of Proton Transmission-Beam Stereotactic Ablative Radiotherapy versus Photon Stereotactic Ablative Radiotherapy for Lung Tumors: A Dosimetric and Feasibility Study
por: Mou, Benjamin, et al.
Publicado: (2014)

A Framework for ExacTrac Dynamic Commissioning for Stereotactic Radiosurgery and Stereotactic Ablative Radiotherapy
por: Perrett, Ben, et al.
Publicado: (2022)

MR-Guided Adaptive Radiotherapy for OAR Sparing in Head and Neck Cancers
por: Mulder, Samuel L., et al.
Publicado: (2022)

Editorial: Online Adaptive MR-Guided Radiotherapy
por: Kerkmeijer, Linda G. W., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_st20muenlt0r9i7b4e2ergtmek